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1. Introduction
Microorganisms can live in one of two possible states:
sessile or planktonic. The sessile phenotype results from 
attachment and usually develops into a bioﬁlm that has un-
ique characteristics [1]. The bioﬁlm is commonly deﬁned as 
‘‘an assemblage of microbial cells that is irreversibly associated 
(not removed by gentle rinsing) with a surface and enclosed in 
a matrix of primarily polysaccharide material.’’ [2]. This 
deﬁni-tion is not entirely satisfactory, since a bioﬁlm may 
be not only an aggregation of bacteria but also, as recently 
deﬁned, ‘‘a microbially derived sessile community 
characterized by cells that are irreversibly attached to a 
substratum or interface or to each other, are embedded in a 
matrix of extracellular polymeric substances that they have 
produced, and exhibit an altered phe-notype with respect to 
growth rate and gene transcription’’ [3]. A bioﬁlm is 
characterized by the adhesion of the cells to a
non exfoliative surface, immersed in an aqueous medium 
and/or on other bacteria cells. The mechanism of attach-
ment may be explained in terms of several factors, namely 
substratum effects, conditioning ﬁlms forming on the sub-
stratum, hydrodynamics of the aqueous medium, 
character-istics of the medium, and various properties of 
the cell surface [2]. The association between bioﬁlms and 
diseases is not always easy, because the bioﬁlm infection 
cannot be proved according to Koch’s postulates [1]. 
Infections strongly linked to a bioﬁlm development, such as 
periodon-tal disease, endodontic infections, candidiasis, 
valve endo-carditis, cystic ﬁbrosis, urinary catheter cystitis, 
have all in common the resistance to non-invasive 
therapies (as drug therapy). The study of this microbial 
state is today indis-pensable to obtain a diagnosis and to 
decide an appropriate therapy [1,4–8]. Bioﬁlm infections 
are often originated by nosocomial infections linked to 
poorly sterilized surfaces of medical devices, entailing 
critical consequences for in-volved patients [1,9,10]. 
Among the microbial species in-volved in bioﬁlm infections 
are some microbes having a
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ABSTRACT
The microbial bioﬁlm is a structure often developed by microorganisms when performing their harmful effects, both 
in the medical and industrial ﬁelds. Therefore, methods allowing identiﬁcation and analysis of the bioﬁlm play a 
fundamental role in determining the kind of intervention needed to avoid these effects. The microtiter 
spectrophotometric assay is rec-ognized as the gold standard method to quantify a bioﬁlm and to analyze the anti-
bioﬁlm activity of various substances. The aim of the present work is to validate this method through an uncertainty 
evaluation, covering eight different microbial species.
The results show that the microtiter spectrophotometric assay is adequate to perform the bioﬁlm analysis, with a good 
reproducibility and a reasonable uncertainty. However, the method requires a thorough knowledge of bio-dynamics 
concerning microbial species tested, in order to perform some protocol improvements catering in turn for better 
results.
Microtiter spectrophotometric bioﬁlm production 
assay analyzed with metrological methods and 
uncertainty evaluation
primary role or considered model organisms for in vitro 
analysis, and therefore are among the most studied 
microbial species (spp) both in vivo and in vitro. Eight of 
these microbes, namely Escherichia coli (Ec), Pseudomonas 
aeruginosa (Pa), Klebsiella pneumonia (Kp), Bacillus subtilis 
(Bs), Enterococcus faecalis (Ef), Staphylococcus aureus (Sa), 
Candida albicans (Ca) and Aggregatibacter 
actynomicetemcom-itans (Aa) [1,4,9–15] (Table 1), were 
considered in this study. The development of a 
reproducible, speciﬁc and sensi-tive bioﬁlm measurement 
method is today necessary in both medical and industrial 
ﬁelds. Among the various methods, indirect and direct 
applications may be distin-guished. Indirect applications, 
such as standard plate counts, roll techniques, and 
sonication, allow the operator to obtain a quantiﬁcation 
analysis of the bioﬁlm after a detaching action. Other 
indirect techniques, such as radio-labeled bacteria, 
enzyme-linked immunosorbent assay,
biologic assays, stained bacterial ﬁlms, and microtiter plate 
procedures, enable the observer to obtain a quantiﬁcation 
evaluation of the bioﬁlm by measuring some attribute for 
the attached organism [16]. While many works in literature 
found limits often linked to the indirect methods [16–18], 
the direct methods show a better performance in terms of 
bioﬁlm assessment, offset however by greater difﬁculties 
associated with techniques and equipment which may not 
be readily available (laser-scanning confocal, transmission 
electron and scanning electron microscopes) [16].
An indirect method which showed a good level of repro-
ducibility, speciﬁcity and sensitivity, along with substantial 
simplicity, is the microtiter or microplate 
spectrophotomet-ric assay [16,19–22]. This method, ﬁrst 
described in 1977 [19] and modiﬁed and improved in 1998 
and in 2002 [20,16], is highly adaptable to the type of 
organisms to be studied in various and different growing 
conditions, is used routinely [23,24], and is nowadays 
considered as the gold standard for the indirect evaluation 
of bioﬁlm [22].
Spectrophotometry, a technique based on the interac-
tion of light and matter, investigates the absorption of
different substances within the wavelength range 190–
780 nm. In this range the absorption of the electromag-
netic radiation is caused by the excitation of the bonding
and non-bonding electrons of the ions or molecules. Spec-
trophotometry is used for both qualitative and quantitative
investigations of samples. The wavelength at the maxi-
mum of the absorption band is related to the amount of
the species absorbing the light.
This work is aimed at validation of the microtiter 
spectrophotometric bioﬁlm production assay as a mea-
surement tool using a metrological approach, exploiting 
statistical methods in order to perform an uncertainty 
evaluation [25].
2. Materials and methods
2.1. Culture preparation
The following species were used for this study:
1. Gram positive bacteria: Staphylococcus aureus ATCC 
6538, Enterococcus faecalis ATCC 29212 [26], Bacillus 
subtilis (clinical strain) [8].
2. Gram negative bacteria: Escherichia coli ATCC 7075, Pseu-
domonas aeruginosa ATCC 27853, Aggregatibacter actino-
mycetemcomitans DSM 11123 (genotype JP2) (Deutsche 
Sammlung von Mikrorganismen und Zellkulturen 
GmbH, Braunschweig, Germany) [26], Klebsiella pneu-
moniae (clinical strain) [27].
3. Fungi: Candida albicans from oral clinical isolates. These
specimens were plated in Sabouraud glucose agar for 
48 h at 35 C (Microbiol, UTA, Cagliari, Italy). The colo-
nies were identiﬁed with an API ID32C system 
(Biomerieux, St Louis, MO) and maintained at 20 C in 
skimmed milk (Oxoid, Basingstoke, UK) [26].
Before the application of the spectrophotometric assay
method, the selected microorganisms were divided into
three groups:
Table 1
Main diseases related to bacterial spp examined; nosocomial infections are
identiﬁed.
Bioﬁlm microbial species Infection or disease Nosocomial
Escherichia coli (Ec) Biliary tract infection NO
Bacterial prostatitis NO
Orthopedic devices
infection
YES
Pseudomonas aeruginosa
(Pa)
Cystic ﬁbrosis NO
Contact lens infection YES
Central venous
catheters infection
YES
Orthopedic devices
infection
YES
Klebsiella pneumonia (Kp) Urinary catheter
cystitis
YES
Central venous
catheters infection
YES
Bacillus subtilis (Bs) Model organism –
Enterococcus faecalis (Ef) Endodontic infection NO
Urinary catheter
cystitis
YES
Mechanical heart
valves infection
YES
Orthopedic devices
infection
YES
Intra-Uterin devices
infection
YES
Staphylococcus aureus (Sa) Arteriovenous shunts
infection
YES
Intra-Uterin devices
infection
YES
Pentile prostheses
infection
YES
Candida albicans (Ca) Candidiasis NO
Vaginitis NO
Peritoneal dialysis
peritonitis
YES
Vascular catheters
infection
YES
Joint prostheses
infection
YES
Central venous
catheters infection
YES
Aggregatibacter
actynomicetemcomitans
(Aa)
Periodontal disease NO
Meningitis NO
Heart disease NO
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(i) Strains of Staphylococcus aureus, Enterococcus faecalis,
Bacillus subtilis, Escherichia coli, Pseudomonas aerugin-
osa and Klebsiella pneumoniae were incubated in
Müller Hinton agar, (MH Microbiol, UTA, Cagliari
Italy) at 37 C for 24 h.
(ii) One strain of Candida albicans was cultured in Sab-
ouraud glucose agar at 37 C for 48 h.
(iii) One strain of Aggregatibacter actinomycetemcomitans
was incubated in Anaerobic difﬁcile agar (Microbiol, 
UTA, Cagliari, Italy) at 37 C for 24 h with a CO2 con-
centration of 5% [28].
After the incubation, group (i) was suspended in Müller 
Hinton broth (MH), group (ii) in Sabouraud glucose broth 
(SAB) and group (iii) in vials containing Schaedler Broth 
(SH) [28]. Bacterial suspensions were performed to obtain 
a concentration with a turbidity equivalent to the No. 3 
McFarland standard (about 108 CFU/ml), then diluted to 
1/100 (obtaining a 106 CFU/ml) using a spectrophotometer 
at 620 nm (DMS100s, Varian, New Hampshire, USA) [6].
2.2. Microtiter plate bioﬁlm production assay
The protocol described in 2007 [22] was applied to per-
form the bioﬁlm analysis. During the application of the 
method, each step was numbered and analyzed, reading at 
620 nm with a microtiter plate reader (Microplate Reader 
TECAN SPECTRA II) for the metrological evaluation. To real-
ize the colorimetric assay, 200 ll of each suspended strain, 
were added to six wells of a 96-well plate and incubated 
for 24 h. After the incubation (STEP 1: initial condition) 
the medium was removed (STEP 2: pre-washing) and the 
microtiter plate wells were washed three times with 
200 ll of PBS (0.1 M, pH 7.4) buffer using a multichannel 
pipette, and allowed to dry for 15 min (STEP 3: post-
washing). The microtiter wells were stained with 200 ll of  
0.4% crystal violet for 15 min at room temperature. The un-
bound crystal violet stain was removed and the wells were 
washed three times with 200 ll of PBS buffer (STEP 4: post-
crystal violet). The wells were air-dried for 15 min and the 
crystal violet in each well was solubilized by adding 
200 ll of 33% acetic acid (STEP 5: post-acetic acid). The 
bioﬁlm value was represented by the analysis of the
absorbance carried out with a spectrophotometer at
620 nm (SLT-Spectra II™, SLT Instruments, Germany).
2.3. Step by step spectrophotometric measurement
During the colorimetric assay, the ﬁve critical steps pre-
viously described, i.e. STEP 1 to STEP 5, were identiﬁed.
Each phase was analyzed through a spectrophotometric
reading at 620 nm obtaining 240 measurements of absor-
bance. In STEP 1 the absorbance value of the bacteria
planktonic growth after the incubation was obtained; it
could be considered as the value representing the develop-
ment of each microorganism in an aqueous medium before
any manipulation. By STEP 2 the value that represents the
turbidity of each well after the broth removal was ob-
tained. STEP 3 determined the absorbance after the ﬁrst
washing phase. In STEP 4 the turbidity of the dried colored
bioﬁlm after washing and before suspension was analyzed.
STEP 5 was the ﬁnal phase of the microtiter plate bioﬁlm
production assay method; by this phase the turbidity of
the colored bioﬁlm suspended by acetic acid may be deter-
mined. Table 2 shows some descriptive statistics (mean
and standard deviation) and values for each specie at each
step, corrected subtracting a relevant C-value different for
each broth (MH, SAB or SH). Since negative values of
absorbance are physically meaningless, such values were
arbitrarily set equal to zero, enabling the evaluation of
metrological characteristics using statistical methods.
2.4. Statistical analysis
An uncertainty evaluation of the whole process has been 
performed according to the GUM [25]. This may be 
properly organized in a tabular format (Table 3), referring 
to EA-4/02:1999 [29]. A minor modiﬁcation was adopted 
by substituting the standard deviations with variances, in 
order to show the individual contribution to the variance of 
output quantity y [30,31].
The considered mathematical model is:
y ¼ x b ð1Þ
where x is the general mean of the means of six
replications of absorbance values considering all the
Table 2
Descriptive statistics for each specie at each step. Means corrected by subtracting the relevant C- value are also shown (negative values were arbitrarily set
equal to zero).
STEP 1 Initial condition STEP 2 Pre-washing STEP 3 Post-washing STEP 4 Post-crystal violet STEP 5 Post-acetic acid
Mean St.
Dev.
Corrected Mean St.
Dev.
Corrected Mean St.
Dev.
Corrected Mean St.
Dev.
Corrected Mean St.
Dev.
Corrected
Kp (MH) 1.381 0.07 1.282 0.134 0.04 0.102 0.093 0.07 0.000 0.087 0.02 0.022 0.273 0.05 0.174
Bs (MH) 0.739 0.07 0.639 0.339 0.12 0.307 0.093 0.06 0.000 0.073 0.07 0.009 0.123 0.03 0.025
Sa (MH) 0.549 0.08 0.449 0.136 0.02 0.104 0.103 0.07 0.008 0.094 0.05 0.030 0.158 0.05 0.060
Pa (MH) 0.933 0.06 0.833 0.113 0.02 0.082 0.113 0.05 0.018 0.109 0.07 0.045 0.138 0.03 0.039
Ec (MH) 0.991 0.04 0.892 0.100 0.02 0.068 0.122 0.04 0.026 0.103 0.08 0.039 0.108 0.03 0.009
Ef (MH) 0.149 0.05 0.049 0.073 0.01 0.041 0.105 0.07 0.009 0.070 0.02 0.006 0.127 0.03 0.029
Ca (SAB) 1.232 0.04 1.145 0.324 0.05 0.289 0.107 0.04 0.000 0.104 0.08 0.028 0.147 0.04 0.051
Aa (SH) 0.359 0.04 0.258 0.247 0.02 0.196 0.270 0.06 0.151 0.274 0.09 0.136 0.380 0.05 0.259
C-(MH) 0.100 0.01 0.032 0.00 0.095 0.04 0.064 0.03 0.099 0.01
C-(SAB) 0.088 0.01 0.035 0.01 0.114 0.01 0.076 0.04 0.096 0.01
C-(SH) 0.101 0.01 0.051 0.04 0.119 0.03 0.138 0.02 0.120 0.01
M. Erriu et al. /Measurement 45 (2012) 1083–1088 1085
microorganisms at each step, while b is the overall mean of
the means of six replications of absorbance values consid-
ering all the C- values at each step. The value of y is
1.9  101.
The resolution of the spectrophotometer is equal to
1  103. The reproducibility, calculated as the standard
deviation of biases from the means of six replications con-
sidering all the absorbance values at each step, was found
equal to 4.4  102.
The resulting expanded uncertainty at 95% conﬁdence
level is 1.2  101, i.e. relative expanded uncertainty of
about 65%.
This value concerns the whole process, namely the ﬁve 
steps referred to above. To detect some possible criticali-
ties of the method, linked to biological behavior or to 
practical implementation, a statistical comparison among 
the ﬁve steps was performed in terms of variance. In par-
ticular, a F-test [32] was exploited to check, for each mi-
crobe, whether there are signiﬁcant differences in terms of 
variability among the different phases (Table 4). Only STEP 
4 for microbe Ec exhibits a variance signiﬁcantly greater 
than the variance of the mean of the ﬁve steps, at a 5% level.
3. Results
3.1. Preliminary results
Given the different strains of microorganisms, they are 
best considered individually. Since the turbidity of the sus-
pended bioﬁlm is the focus of the method, STEP 5 was 
examined in detail. In this step, considering absorbance 
values corrected with respect to C-values, Ec, Ef, Bs show 
some negative values, making the evaluation of the uncer-
tainty meaningless. Furthermore, Pa, Sa, Ca exhibited a 
very large variability, entailing excessively large values of 
uncertainty. On the other hand, results related to Kp and 
Aa showed an acceptable variability. The method described 
in Table 3 was applied, obtaining values of the relative ex-
panded uncertainty, respectively, equal to 28% for Kp and 
to 22% for Aa (Table 5). The experiments were repeated 
for Ec, Kp and Aa in order to improve the method.
3.2. Method improvement
The preliminary analysis enabled identiﬁcation of
some critical phases with step-by-step spectrophotomet-
Table 3
Uncertainty table, showing main contributions and resulting expanded uncertainty.
xj sj aj kaj u
2(xj) cj u2j ðyÞ mj u4j ðyÞ=mj
Symbol Value Note
x 0.279 Res 5.0E04 3 8.3E08 1.0E + 00 8.3E08 100 6.9E17
Repr. 4.4E02 2.0E03 1.0E + 00 2.0E03 100 3.9E08
b 0.089 Res 5.0E04 3 8.3E08 1.0E + 00 8.3E08 100 6.9E17
Repr. 4.4E02 2.0E03 1.0E + 00 2.0E03 100 3.9E08
y 0.191 Variance of y, u2(y) 3.9E03 R 7.7E08
Standard deviation of y, u(y) 6.3E02 my 200
Conﬁdence level 95%
Coverage factor (Student’s t) 2.0
Expanded uncertainty, U(y) 1.2E-01
Table 4
F-test relative to the variability among different phases of all species. The F value at 95% conﬁdence level is 2.60, since the degrees of freedom are 5 for the
numerator and 25 for the denominator. Only STEP 4 exhibits a signiﬁcant variance ratio for Ec (bold number), the signiﬁcance level is barely approached for Aa
and Ca.
Var m STEP 1 Initial condition STEP 2 Pre-washing STEP 3 Post-washing STEP 4 Post-crystal violet STEP 5 Post-acetic acid
Var Var ratio Var Var ratio Var Var ratio Var Var ratio Var Var ratio
Kp 0.003 0.005 1.82 0.002 0.64 0.005 1.68 <0.001 0.10 0.002 0.76
Bs 0.006 0.005 0.83 0.014 2.50 0.004 0.65 0.005 0.90 0.001 0.12
Sa 0.003 0.006 1.92 <0.001 0.12 0.005 1.53 0.002 0.73 0.002 0.70
Pa 0.003 0.004 1.58 <0.001 0.09 0.002 0.88 0.006 2.12 0.001 0.33
Ec 0.002 0.002 0.75 <0.001 0.12 0.002 0.82 0.006 2.80 0.001 0.52
Ef 0.002 0.003 1.58 <0.001 0.05 0.004 2.46 <0.001 0.28 0.001 0.63
Ca 0.003 0.002 0.56 0.003 1.03 0.002 0.58 0.007 2.33 0.001 0.50
Aa 0.003 0.002 0.52 <0.001 0.14 0.003 1.04 0.008 2.46 0.003 0.84
Table 5
Mean values, relevant absolute and relative expanded uncertainties (95% conﬁdence level), before and after the method improvement.
Before improvement After improvement
m U U/m m U U/m (%)
Ec – – – 0.051 0.013 26
Kp 0.174 0.049 28% 0.546 0.124 22
Aa 0.259 0.057 22% 0.147 0.063 43
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3.3. Final results
After improvement of the method, values of the relative 
expanded uncertainty equal to 26% for Ec, 22% for Kp, and 
43% for Aa (Table 5), were obtained. On the other hand, com-
paring the values of absorbance before and after improve-
ment of the method, Kp showed the highest values (Fig. 2).
4. Discussion
Themicrobial bioﬁlm development process is strictly re-
lated to the presence or absence of a variety of inﬂuencing 
factors [21]. Bacterial metabolism, genotype presence or 
ab-sence of speciﬁc nutrients, level of O2, pH, temperature 
are some examples of factors which could up- or down-
regulate bioﬁlm both quantitatively and qualitatively 
[21,24]. Bear-ing this in mind, since the bioﬁlm is a 
dynamic structure, slight alterations among experiments 
may result into very different growth in vitro. Therefore 
comparative experi-ments with the method described 
above are best performed at the same time with the same 
conditions, since compari-son among absorbance values 
obtained for the same bacte-ria grown in different times 
and/or under different conditions might yield inconsistent 
results.
Observing STEP 1 before and after improvement of the
method, signiﬁcant differences at the 95% conﬁdence level
for Aa and Kp planktonic growth may be observed, with a
marked reduction of dispersion. In fact, Aa shows in STEP
1 of the ﬁrst test a mean value of absorbance equal to
0.36 with an upper conﬁdence limit of 0.40 and a lower
conﬁdence limit of 0.32, while in the second test the mean
decreases to 0.29 with limits of 0.30 and 0.27. Accordingly,
Fig. 1. The multichannel pipette (bottom) was substituted by the single
pipette (top) to improve the method.
Fig. 2. Bar diagram pertaining to replicated spectrophotometric measurements for Kp (absorbance values before and after the method improvement).
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Kp shows in STEP 1 of the ﬁrst test a mean of 1.38 with lim-
its equal to 1.46 and 1.31, while in the second test these
values change to a mean of 1.22 and limits of 1.24 and
1.21. Ec showed a similar planktonic growth in both tests
obtaining a mean of 0.99 before the method improvement
and of 1.00 after the method improvement, with limits
equal to 1.03 and 0.95 against 1.06 and 0.95. These results
highlight the growth stability of this bacteria, supporting
the choice of Ec as a standard for studies in the microbio-
logical ﬁeld. The different growth rates showed by Aa
and Kp may not be easily explained, since in both tests
the same protocol performing the cultural phase was ap-
plied; some uncontrolled environmental factor may some-
how inﬂuenced the bacterial growth.
Further considerations are necessary to understand 
why the method showed substantially different results be-
tween different microbial species. In the ﬁrst analysis, for 
some microbial species bioﬁlm analysis was made impos-
sible by negative results and/or excessive variability. These 
problems may be related to a too light and thin bioﬁlm; 
indeed, the bioﬁlm is a microbial structure linked to both 
virulence and preservation, as well as the result of an intra-
species cooperation [5,6,24]. Experiments in vitro may not 
readily replicate the conditions necessary to determine the 
development of virulence factors, as the analysis of each 
microorganism alone (necessary to under-stand the 
biodynamic linked to the bioﬁlm development) implies the 
formation of a much thinner bioﬁlm than when many 
bacteria grow together. The use of antibacterial sub-stances 
at low concentrations might determine the forma-tion of a 
thicker bioﬁlm, however this could negate comparison 
among different microorganisms.
The improvement of the method enabled to determine 
Kp and Ec bioﬁlms with a reasonable uncertainty thanks 
to a major compliance with the bioﬁlm light base-struc-
ture, on the contrary Aa showed the worst results with re-
spect to the ﬁrst analysis (see Table 5). This problem may 
be explained by the bio-dynamic of Aa; during the plank-
tonic growth, this bacteria forms micelle with consequent 
precipitation on the bottom of the walls, so that these 
structures, while not participating in the formation of the 
bioﬁlm, develop a weak adhesion to the bioﬁlm surface 
[23,24]. Previous studies show that removal of loosely 
adherent or non-adherent cells requires many washings, up 
to 15, i.e. 6 more than the base protocol [23].
In conclusion, the microtiter spectrophotometric assay
proved to be a valid method to perform bioﬁlm analysis
and measurements. Key factors for proper use are knowl-
edge of the dynamics of the bioﬁlm formation of the species
to be tested, and application of the method on all samples
simultaneously when performing comparative studies.
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